Omada Raises Full-Year 2026 Guidance Following Strong Third Quarter Growth
Omada (OMDA) reported strong third-quarter 2026 financial results, highlighted by a 34% year-over-year revenue increase to $91 million and a 36% rise in total membership to 1.13 million. Driven by high retention in cardiometabolic programs and improved operational efficiency through AI automation, the company achieved positive net income and record low care delivery costs. In response to these results, management raised its full-year revenue guidance to a range of $344 million to $346 million and increased its adjusted EBITDA outlook. The company's strategic positioning allows it to remain resilient regardless of employer coverage for GLP-1 medications, as its product tracks accommodate both prescribing support and lifestyle interventions.
Tickers: $OMDA
Topics: digital health earnings report EBITDA guidance raise revenue growth
Read the full article at Motley Fool
Part of the story AAON Shares Surge 22% Following Third-Quarter Earnings Beat and Raised Full-Year Guidance (29 articles)